Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session - Adicet Bio (NASDAQ:ACET)

Gainers

Losers

Also check this out Bitcoin Drops But Remains Above This Key Level; Chiliz, Dogecoin Among Top Losers.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Posted In:

News Penny Stocks Small Cap Intraday Update Markets Movers Trading Ideas Mid-Day Movers Top Gainers

Gainers

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Harpoon Therapeutics, Inc. (NASDAQ:HARP) rose 97.3% to $2.27 after the company announced it presented updated interim results at ASH 2022 for novel T cell engager HPN217 in relapsed/refractory multiple myeloma.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) gained 85% to $0.69 after the company announced the exclusive license of potential therapeutic or preventative humanized anti-SARS-CoV-2 monoclonal antibodies from Curia Global.
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares climbed 65.6% to $5.68 after the company announced that APVO436, in combination with venetoclax and azacitidine, achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients.
Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 56.2% to $0.4612 after gaining over 11% on Friday. Faraday Future Intelligent Electric recently appointed FF China CEO Xuefeng (XF) Chen as Global CEO of the company, effective immediately.
China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) jumped 39.9% to $4.63 after jumping 53% on Friday.
Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) surged 34.5% to $14.80.
Virax Biolabs Group Limited (NASDAQ:VRAX) jumped 28.7% to $1.30.
United Insurance Holdings Corp. (NASDAQ:UIHC) gained 28.3% to $0.4297. The company, last month, posted downbeat quarterly results.
Reborn Coffee, Inc. (NASDAQ:REBN) rose 28.3% to $1.3602 after jumping around 22% on Friday. Reborn Coffee recently signed a Letter of Intent to acquire a specialty coffee shop and a roasting research and development facility in Daejeon, South Korea as a part of its global expansion plan.
Coupa Software Incorporated (NASDAQ:COUP) shares gained 26.6% to $78.63 after the company announced it will be acquired by Thoma Bravo for $8 billion.
BIMI International Medical, Inc. (NASDAQ:BIMI) gained 25% to $2.60. BIMI recently announced a 1-for-10 reverse stock split.
Weber Inc. (NYSE:WEBR) jumped 24.9% to $8.12 after the company entered an agreement to be taken private by BDT Capital Partners for $8.05 per share.
Avalon GloboCare Corp. (NASDAQ:ALBT) gained 24.4% to $0.3980. Avalon GloboCare announced a new proposed board composition in preparation for acquisition of Laboratory Services MSO, LLC.
Kingstone Companies, Inc. (NASDAQ:KINS) jumped 22% to $1.33.
Bruush Oral Care Inc. (NASDAQ:BRSH) shares rose 21.6% to $0.59. Bruush Oral Care reported closing of $3.0 million private placement.
EZFill Holdings Inc. (NASDAQ:EZFL) gained 19% to $0.46. EzFill Holdings, last month, posted a Q3 loss of $0.15 per share.
Chemomab Therapeutics Ltd. (NASDAQ:CMMB) jumped 15% to $2.7601.
Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) rose 14.6% to $111.48 after Amgen announced it will acquire the company for $116.50 per share in cash.
Studio City International Holdings Limited (NYSE:MSC) gained 14% to $5.33.
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) jumped 13.7% to $28.20.
111, Inc. (NASDAQ:YI) gained 13% to $3.73. 111 recently posted Q3 adjusted loss of $0.10 per share.
Oriental Culture Holding LTD (NASDAQ:OCG) gained 12.9% to $0.8355.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) rose 11.5% to $0.6471 after gaining over 20% on Friday.
Connexa Sports Technologies Inc. (NASDAQ:CNXA) gained 10.8% to $0.18.
Cogent Biosciences, Inc. (NASDAQ:COGT) jumped 10.7% to $12.29 after the company announced updated clinical data from ongoing Phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis.
Pitney Bowes Inc. (NYSE:PBI) jumped 9.4% to $4.19. Hestia Capital confirmed intent to overhaul Pitney Bowes' board of directors following 10+ years of significant value destruction under Chair Michael Roth and CEO Marc Lautenbach.
Frontline Ltd. (NYSE:FRO) gained 8.8% to $13.95. Frontline, last week, issued a Form424B3 filing highlighting a proposal to increase the company’s authorized share capital from $500 million to $600 million.
HashiCorp, Inc. (NYSE:HCP) jumped 7.6% to $31.87. HashiCorp recently reported better-than-expected Q3 sales results.

Losers

Affimed N.V.. (NASDAQ:AFMD) fell 39.2% to $1.24 after the company announced topline data from its Phase 2 REDIRECT study of AFM13 monotherapy in patients with advanced-stage relapsed/refractory peripheral T cell lymphoma.
Ambrx Biopharma Inc. (NYSE:AMAM) fell 38.3% to $2.7991. Ambrx Biopharma shares jumped over 1,007% on Friday after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
Adicet Bio, Inc. (NASDAQ:ACET) shares fell 37.2% to $10.85 after the company announced safety and efficacy data from its ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell NHL.
Rockley Photonics Holdings Limited (NASDAQ:RKLY) dropped 34.8% to $0.2601.
TeraWulf Inc. (NASDAQ:WULF) dipped 31% to $0.8388. TeraWulf increased expected Q1 2023 self-mining hash rate at no additional cost and announced repayment of certain debt.
SHF Holdings, Inc. (NASDAQ:SHFS) fell 26.6% to $2.43.
Curis, Inc. (NASDAQ:CRIS) fell 25.1% to $0.5744 after the company announced additional clinical data from TakeAim Leukemia study of emavusertib in monotherapy R/R AML and hrMDS.
Fangdd Network Group Ltd. (NASDAQ:DUO) dropped 23.2% to $0.9369. Xi Zeng recently disclosed a 6.5% active stake in Fangdd Network Group Ltd.
Appreciate Holdings, Inc. (NASDAQ:SFR) declined 20.3% to $2.20.
Inotiv, Inc. (NASDAQ:NOTV) fell 20.2% to $4.5350 after the company issued FY22 sales guidance below estimates.
Baudax Bio, Inc (NASDAQ:BXRX) shares fell 16.8% to $4.3261. Baudax Bio shares gained around 28% on Friday after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
HUYA Inc. (NYSE:HUYA) fell 16.3% to $2.9050. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
TAL Education Group (NYSE:TAL) dipped 16% to $5.55.
Baozun Inc. (NASDAQ:BZUN) fell 15.3% to $4.91. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
DouYu International Holdings Limited (NASDAQ:DOYU) dropped 14.9% to $1.2850. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
Fate Therapeutics, Inc. (NASDAQ:FATE) fell 14.6% to $16.10. GT Biopharma and Fate Therapeutics presented preclinical data highlighting novel dual antigen targeting approach for the treatment of AML at ASH 2022.
Dada Nexus Limited (NASDAQ:DADA) dropped 14% to $6.34. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
UpHealth, Inc. (NYSE:UPH) fell 13.5% to $2.1180.
Lufax Holding Ltd (NYSE:LU) declined 13.4% to $1.9909. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
Hello Group Inc. (NASDAQ:MOMO) dropped 13.2% to $7.75.
Hillstream BioPharma, Inc. (NASDAQ:HILS) fell 11.5% to $0.5389 after climbing 43% on Friday. Hillstream BioPharma recently company announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1.
Meta Materials Inc. (NASDAQ:MMAT) fell 11.3% to $1.26 after dipping 22% on Friday. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META's Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.
Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares fell 10.8% to $1.07 after jumping 21% on Friday. Ensysce Biosciences recently announced pricing of a $4.1 million public offering.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 7.2% to $0.0917.

Also check this out Bitcoin Drops But Remains Above This Key Level; Chiliz, Dogecoin Among Top Losers.

ACETAdicet Bio Inc

$6.72-%

Overview

ALBTAvalon Globocare Corp

$0.88694.43%

APVOAptevo Therapeutics Inc

$6.57-0.30%

BIMIBIMI Holdings Inc

$0.00010-100.0%

BZUNBaozun Inc

$2.57-2.28%

CMMBChemomab Therapeutics Ltd

$1.48-%

COGTCogent Biosciences Inc

$36.820.27%

CRISCuris Inc

$1.101.40%

DFLIDragonfly Energy Holdings Corp

$2.29-%

DOYUDouYu International Holdings Ltd

$5.64-0.70%

DUOFangdd Network Group Ltd

$1.194.20%

ENSCEnsysce Biosciences Inc

$0.3984-3.54%

FATEFate Therapeutics Inc

KINSKingstone Companies Inc

MSCStudio City International Holdings Ltd

$3.24-1.82%

NOTVInotiv Inc

$0.2806-3.31%

OCGOriental Culture Holding Ltd

$1.19-1.65%

PBIPitney Bowes Inc

$10.03-1.37%

PBLAPanbela Therapeutics Inc

$0.0111-99.1%

REBNReborn Coffee Inc

$1.9015.2%

SHFSSHF Holdings Inc

$0.98004.58%

SXTCChina SXT Pharmaceuticals Inc

$2.661.25%

TALTAL Education Group

$11.30-1.57%

TNXPTonix Pharmaceuticals Holding Corp

$15.200.66%

VRAXVirax Biolabs Group Ltd

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Posted In:

News Penny Stocks Small Cap Intraday Update Markets Movers Trading Ideas Mid-Day Movers Top Gainers

Comments

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Harpoon Therapeutics, Inc. (NASDAQ:HARP) rose 97.3% to $2.27 after the company announced it presented updated interim results at ASH 2022 for novel T cell engager HPN217 in relapsed/refractory multiple myeloma.
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) gained 85% to $0.69 after the company announced the exclusive license of potential therapeutic or preventative humanized anti-SARS-CoV-2 monoclonal antibodies from Curia Global.
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares climbed 65.6% to $5.68 after the company announced that APVO436, in combination with venetoclax and azacitidine, achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients.
Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 56.2% to $0.4612 after gaining over 11% on Friday. Faraday Future Intelligent Electric recently appointed FF China CEO Xuefeng (XF) Chen as Global CEO of the company, effective immediately.
China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) jumped 39.9% to $4.63 after jumping 53% on Friday.
Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) surged 34.5% to $14.80.
Virax Biolabs Group Limited (NASDAQ:VRAX) jumped 28.7% to $1.30.
United Insurance Holdings Corp. (NASDAQ:UIHC) gained 28.3% to $0.4297. The company, last month, posted downbeat quarterly results.
Reborn Coffee, Inc. (NASDAQ:REBN) rose 28.3% to $1.3602 after jumping around 22% on Friday. Reborn Coffee recently signed a Letter of Intent to acquire a specialty coffee shop and a roasting research and development facility in Daejeon, South Korea as a part of its global expansion plan.
Coupa Software Incorporated (NASDAQ:COUP) shares gained 26.6% to $78.63 after the company announced it will be acquired by Thoma Bravo for $8 billion.
BIMI International Medical, Inc. (NASDAQ:BIMI) gained 25% to $2.60. BIMI recently announced a 1-for-10 reverse stock split.
Weber Inc. (NYSE:WEBR) jumped 24.9% to $8.12 after the company entered an agreement to be taken private by BDT Capital Partners for $8.05 per share.
Avalon GloboCare Corp. (NASDAQ:ALBT) gained 24.4% to $0.3980. Avalon GloboCare announced a new proposed board composition in preparation for acquisition of Laboratory Services MSO, LLC.
Kingstone Companies, Inc. (NASDAQ:KINS) jumped 22% to $1.33.
Bruush Oral Care Inc. (NASDAQ:BRSH) shares rose 21.6% to $0.59. Bruush Oral Care reported closing of $3.0 million private placement.
EZFill Holdings Inc. (NASDAQ:EZFL) gained 19% to $0.46. EzFill Holdings, last month, posted a Q3 loss of $0.15 per share.
Chemomab Therapeutics Ltd. (NASDAQ:CMMB) jumped 15% to $2.7601.
Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) rose 14.6% to $111.48 after Amgen announced it will acquire the company for $116.50 per share in cash.
Studio City International Holdings Limited (NYSE:MSC) gained 14% to $5.33.
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) jumped 13.7% to $28.20.
111, Inc. (NASDAQ:YI) gained 13% to $3.73. 111 recently posted Q3 adjusted loss of $0.10 per share.
Oriental Culture Holding LTD (NASDAQ:OCG) gained 12.9% to $0.8355.
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) rose 11.5% to $0.6471 after gaining over 20% on Friday.
Connexa Sports Technologies Inc. (NASDAQ:CNXA) gained 10.8% to $0.18.
Cogent Biosciences, Inc. (NASDAQ:COGT) jumped 10.7% to $12.29 after the company announced updated clinical data from ongoing Phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis.
Pitney Bowes Inc. (NYSE:PBI) jumped 9.4% to $4.19. Hestia Capital confirmed intent to overhaul Pitney Bowes' board of directors following 10+ years of significant value destruction under Chair Michael Roth and CEO Marc Lautenbach.
Frontline Ltd. (NYSE:FRO) gained 8.8% to $13.95. Frontline, last week, issued a Form424B3 filing highlighting a proposal to increase the company’s authorized share capital from $500 million to $600 million.
HashiCorp, Inc. (NYSE:HCP) jumped 7.6% to $31.87. HashiCorp recently reported better-than-expected Q3 sales results.

Affimed N.V.. (NASDAQ:AFMD) fell 39.2% to $1.24 after the company announced topline data from its Phase 2 REDIRECT study of AFM13 monotherapy in patients with advanced-stage relapsed/refractory peripheral T cell lymphoma.
Ambrx Biopharma Inc. (NYSE:AMAM) fell 38.3% to $2.7991. Ambrx Biopharma shares jumped over 1,007% on Friday after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
Adicet Bio, Inc. (NASDAQ:ACET) shares fell 37.2% to $10.85 after the company announced safety and efficacy data from its ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell NHL.
Rockley Photonics Holdings Limited (NASDAQ:RKLY) dropped 34.8% to $0.2601.
TeraWulf Inc. (NASDAQ:WULF) dipped 31% to $0.8388. TeraWulf increased expected Q1 2023 self-mining hash rate at no additional cost and announced repayment of certain debt.
SHF Holdings, Inc. (NASDAQ:SHFS) fell 26.6% to $2.43.
Curis, Inc. (NASDAQ:CRIS) fell 25.1% to $0.5744 after the company announced additional clinical data from TakeAim Leukemia study of emavusertib in monotherapy R/R AML and hrMDS.
Fangdd Network Group Ltd. (NASDAQ:DUO) dropped 23.2% to $0.9369. Xi Zeng recently disclosed a 6.5% active stake in Fangdd Network Group Ltd.
Appreciate Holdings, Inc. (NASDAQ:SFR) declined 20.3% to $2.20.
Inotiv, Inc. (NASDAQ:NOTV) fell 20.2% to $4.5350 after the company issued FY22 sales guidance below estimates.
Baudax Bio, Inc (NASDAQ:BXRX) shares fell 16.8% to $4.3261. Baudax Bio shares gained around 28% on Friday after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
HUYA Inc. (NYSE:HUYA) fell 16.3% to $2.9050. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
TAL Education Group (NYSE:TAL) dipped 16% to $5.55.
Baozun Inc. (NASDAQ:BZUN) fell 15.3% to $4.91. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
DouYu International Holdings Limited (NASDAQ:DOYU) dropped 14.9% to $1.2850. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
Fate Therapeutics, Inc. (NASDAQ:FATE) fell 14.6% to $16.10. GT Biopharma and Fate Therapeutics presented preclinical data highlighting novel dual antigen targeting approach for the treatment of AML at ASH 2022.
Dada Nexus Limited (NASDAQ:DADA) dropped 14% to $6.34. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
UpHealth, Inc. (NYSE:UPH) fell 13.5% to $2.1180.
Lufax Holding Ltd (NYSE:LU) declined 13.4% to $1.9909. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
Hello Group Inc. (NASDAQ:MOMO) dropped 13.2% to $7.75.
Hillstream BioPharma, Inc. (NASDAQ:HILS) fell 11.5% to $0.5389 after climbing 43% on Friday. Hillstream BioPharma recently company announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1.
Meta Materials Inc. (NASDAQ:MMAT) fell 11.3% to $1.26 after dipping 22% on Friday. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META's Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.
Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares fell 10.8% to $1.07 after jumping 21% on Friday. Ensysce Biosciences recently announced pricing of a $4.1 million public offering.
Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 7.2% to $0.0917.

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

Gainers

Losers

Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

Gainers

Losers